Tabula Rasa HealthCare (TRHC) Stock Price
Tabula Rasa HealthCare Price
Revenue has compounded at 31.7% per year over the past 9 years to 299.52 M USD. Tabula Rasa HealthCare's net margin stands at -25.8%, down from -23.1% several years earlier.
Tabula Rasa HealthCare stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Tabula Rasa HealthCare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Tabula Rasa HealthCare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Tabula Rasa HealthCare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Tabula Rasa HealthCare Price |
|---|
Tabula Rasa HealthCare Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Tabula Rasa HealthCare Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.00 | 48.00 | 70.00 | 94.00 | 134.00 | 204.00 | 284.00 | 297.00 | 331.00 | 299.00 | 362.00 | 416.00 | 468.00 | 403.00 |
| – | 92.00 | 45.83 | 34.29 | 42.55 | 52.24 | 39.22 | 4.58 | 11.45 | -9.67 | 21.07 | 14.92 | 12.50 | -13.89 |
| 16.00 | 20.83 | 28.57 | 29.79 | 29.85 | 32.35 | 36.27 | 30.98 | 29.31 | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 |
| 4.00 | 10.00 | 20.00 | 28.00 | 40.00 | 66.00 | 103.00 | 92.00 | 97.00 | 66.00 | 79.91 | 91.83 | 103.30 | 88.96 |
| -2.00 | – | 6.00 | 4.00 | 5.00 | – | -28.00 | -57.00 | -69.00 | -67.00 | -27.00 | -23.00 | -65.00 | -6.00 |
| -8.00 | – | 8.57 | 4.26 | 3.73 | – | -9.86 | -19.19 | -20.85 | -22.41 | -7.46 | -5.53 | -13.89 | -1.49 |
| -3.00 | -1.00 | -2.00 | -6.00 | 14.00 | -47.00 | -32.00 | -80.00 | -79.00 | -77.00 | – | 6.00 | -6.00 | – |
| – | -66.67 | 100.00 | 200.00 | -333.33 | -435.71 | -31.91 | 150.00 | -1.25 | -2.53 | – | – | -200.00 | – |
| 24.94 | 9.86 | 9.86 | 16.63 | 19.86 | 19.43 | 20.93 | 22.55 | 23.47 | 24.94 | 24.94 | 24.94 | 24.94 | 24.94 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Tabula Rasa HealthCare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Tabula Rasa HealthCare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Tabula Rasa HealthCare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Tabula Rasa HealthCare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Tabula Rasa HealthCare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Tabula Rasa HealthCare stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Tabula Rasa HealthCare Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Tabula Rasa HealthCare business model & stock analysis
Tabula Rasa HealthCare SWOT Analysis
Strengths
Tabula Rasa HealthCare Inc has several strengths that contribute to its success. Firstly, the company offers innovative healthcare technology solutions that enhance medication safety and optimize patient outcomes. This unique selling point sets them apart from competitors and attracts healthcare providers seeking advanced solutions. Additionally, Tabula Rasa HealthCare Inc has a strong financial position, allowing for continued investment in research and development and future growth opportunities. The company's well-established partnerships with leading healthcare organizations also enhance its credibility and market presence.
Weaknesses
Despite its strengths, Tabula Rasa HealthCare Inc has a few weaknesses that need to be addressed. One major weakness is its dependency on key strategic partnerships, which could create vulnerability if those partnerships dissolve or are compromised. Furthermore, the company may face challenges related to the adoption of its advanced technology solutions, as some healthcare providers may be resistant to change or have concerns regarding the integration process. Additionally, Tabula Rasa HealthCare Inc operates in a highly regulated industry, which may pose compliance challenges and increase operational complexities.
Opportunities
Tabula Rasa HealthCare Inc has several opportunities to capitalize on. Firstly, there is a growing demand for innovative healthcare technology solutions, driven by the need for improved patient outcomes and cost savings. This presents an opportunity for Tabula Rasa HealthCare Inc to expand its customer base and increase market penetration. The company can also explore strategic partnerships with healthcare providers and organizations looking to enhance medication safety and optimize their patient care processes. Furthermore, the aging population and the increasing need for personalized medication therapy make it an ideal time for Tabula Rasa HealthCare Inc to tap into this market segment and develop targeted solutions.
Threats
Tabula Rasa HealthCare Inc needs to be aware of potential threats that could impact its business. One significant threat is strong competition from other healthcare technology solution providers. The industry is constantly evolving, and new players may enter the market with similar or better offerings. Additionally, regulatory changes and evolving policies in the healthcare industry can pose challenges to Tabula Rasa HealthCare Inc's operations and compliance. The global economic landscape and changes in healthcare spending patterns may also impact customer demand and the company's financial performance.
Tabula Rasa HealthCare Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Tabula Rasa HealthCare Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Tabula Rasa HealthCare historical P/E ratio, EBIT multiple, and P/S ratio
Tabula Rasa HealthCare annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Tabula Rasa HealthCare shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Tabula Rasa HealthCare Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 8/7/2023 | Downgrade | OutperformMarket Perform | – | |
| 8/6/2023 | Downgrade | OutperformMarket Perform | – | |
| 5/10/2023 | Upgrade | Market PerformOutperform | – | |
| 5/9/2023 | Upgrade | Market PerformOutperform | – | |
| 11/7/2022 | Maintained | Neutral | 53 | |
| 11/6/2022 | Maintained | Neutral | 53 | |
| 8/18/2022 | Maintained | Neutral | 53 | |
| 8/17/2022 | Maintained | Neutral | 53 | |
| 8/8/2022 | Maintained | Market Perform | – | |
| 8/7/2022 | Maintained | Market Perform | – |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Tabula Rasa HealthCare Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 5/6/2024 | 0.02USD | - | 100.73 MUSD | - | 2024 Q1 |
| 3/4/2024 | 0.02USD | - | 95.24 MUSD | - | 2023 Q4 |
| 8/2/2023 | -0.12USD | - | 83.58 MUSD | - | 2023 Q2 |
| 5/3/2023 | -0.17USD | - | 77.42 MUSD | - | 2023 Q1 |
| 2/22/2023 | -0.06USD | - | 79.74 MUSD | - | 2022 Q4 |
| 11/3/2022 | -0.11USD | - | 75.13 MUSD | - | 2022 Q3 |
| 8/4/2022 | -0.12USD | - | 69.34 MUSD | - | 2022 Q2 |
| 5/5/2022 | -0.16USD | - | 86.16 MUSD | - | 2022 Q1 |
| 2/24/2022 | -0.08USD | - | 86.47 MUSD | - | 2021 Q4 |
| 11/4/2021 | 0.03USD | - | 89.85 MUSD | - | 2021 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Tabula Rasa HealthCare stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Tabula Rasa HealthCare shareholder structure
| % | Name |
|---|---|
26.84495% | |
4.72909% | |
3.42181% | |
3.40287% | |
2.87011% | |
2.46852% |
Tabula Rasa HealthCare Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
19.99% | SEC ↗ | |
19.99% | SEC ↗ | |
19.99% | SEC ↗ | |
11.20% | SEC ↗ | |
11.00% | SEC ↗ | |
10.71% | SEC ↗ | |
6.22% | SEC ↗ | |
6.20% | SEC ↗ | |
6.20% | SEC ↗ | |
5.80% | SEC ↗ |
Tabula Rasa HealthCare Executives and Management Board
14 members · avg. age 60 · 29 % women
Mr. Brian Adams (42)
President, Chief Executive Officer, Director · since 2014
2.30 M USD
Management
Mr. Michael Greenhalgh (61)
Co-Founder, Chief Operating Officer, President - Pharmacy Services
Mr. Thomas Cancro (55)
Chief Financial Officer
Ms. April Gill
Chief Commercial Officer
Mr. Richard Rew (55)
Chief Legal Officer, Corporate Secretary
Mr. Frank Sparacino
IR Contact Officer · since 2019
Board of Directors
Mr. Michael Purcell (66)
Independent Chairman of the Board
Mr. Jonathan Schwartz (61)
Independent Director
Mr. Ronald Mitchell (52)
Independent Director
Mr. Derek Schrier (56)
Independent Director
Dr. Samira Beckwith (70)
Independent Director
Dr. Dennis Helling (74)
Independent Director
Frequently asked questions about Tabula Rasa HealthCare
Tabula Rasa HealthCare Inc is a healthcare technology company that offers personalized medication safety solutions. Their business model involves developing and deploying technology solutions to enhance patient care and optimize medication management. By leveraging data analytics and proprietary systems, Tabula Rasa provides healthcare organizations with tools to identify and mitigate medication risks, improve patient outcomes, and reduce costs. Through their software platforms, such as MedWise and CareKinesis, Tabula Rasa helps healthcare providers optimize medication regimens and address medication-related challenges. By providing tailored solutions, Tabula Rasa HealthCare Inc aims to enhance medication safety for patients and improve overall healthcare quality.
Tabula Rasa HealthCare Inc is primarily active in the healthcare industry.
The main competitors of Tabula Rasa HealthCare Inc in the market include OptumRx, Cerner Corporation, and McKesson Corporation.
Tabula Rasa HealthCare Inc. is a prominent healthcare technology company with a rich history and background. Founded in 2009, Tabula Rasa HealthCare Inc. specializes in providing innovative solutions for personalized medication management. Through its advanced software platforms and clinical decision support tools, the company aims to improve patient care and reduce healthcare costs. Tabula Rasa HealthCare Inc. offers a wide range of services, including medication risk mitigation, pharmacogenomic testing, and electronic health record integration. With a focus on enhancing patient safety and outcomes, Tabula Rasa HealthCare Inc. has become a trusted name in the healthcare industry, providing cutting-edge solutions for healthcare providers and systems.
Some significant milestones achieved by Tabula Rasa HealthCare Inc include its successful IPO in 2014, being listed on the NASDAQ stock exchange, and consistently delivering strong financial performance. The company has experienced rapid growth and expansion, with acquisitions of Mediture and CareKinesis, further enhancing their offering in personalized medication management services. Tabula Rasa HealthCare Inc has also received several prestigious awards and recognitions, including being named one of the fastest-growing companies by Inc. 5000. These achievements highlight the company's commitment to innovation, strategic acquisitions, and driving positive patient outcomes in the healthcare industry.
Tabula Rasa HealthCare Inc is primarily present in the United States.
Tabula Rasa HealthCare Inc is guided by its core values of integrity, innovation, and collaboration. With a strong corporate philosophy focused on improving healthcare outcomes, Tabula Rasa HealthCare Inc is dedicated to providing personalized medication risk mitigation solutions. The company's mission is to optimize medication regimens for individuals, ensuring safer and more effective healthcare practices. Tabula Rasa HealthCare Inc's commitment to innovation and collaboration helps them drive positive change in the healthcare industry, ultimately benefiting patients and providers. By staying true to its values and corporate philosophy, Tabula Rasa HealthCare Inc aims to revolutionize medication safety and improve patient well-being.
9 analysts currently rate the Tabula Rasa HealthCare stock: 0 recommend buying, 6 holding and 3 selling.
The Tabula Rasa HealthCare share (TRHC) is listed on 3 stock exchanges, including: NASDAQ (TRHC), Frankfurt (43T.F), München (43T.MU).
Tabula Rasa HealthCare Inc. (TRHC) is a US company that offers health IT solutions and supports its customers in promoting medication therapy safety. The company provides services in three divisions: Medication Risk Mitigation, Pharmacy Services, and CareVention HealthCare.
The revenue cannot currently be calculated for Tabula Rasa HealthCare.
The profit cannot currently be calculated for Tabula Rasa HealthCare.
The P/E ratio cannot be calculated for Tabula Rasa HealthCare at the moment.
The P/S cannot be calculated for Tabula Rasa HealthCare currently.
The Eulerpool Quality Score for Tabula Rasa HealthCare is 1/10.
The ISIN of Tabula Rasa HealthCare is US8733791011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Tabula Rasa HealthCare is A2ASWL. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Tabula Rasa HealthCare is TRHC. The ticker symbol is used to trade Tabula Rasa HealthCare shares on the stock exchange.
Tabula Rasa HealthCare is assigned to the 'Health' sector.
The dividends of Tabula Rasa HealthCare are distributed in USD.
Tabula Rasa HealthCare stock
Tabula Rasa HealthCare Peer Group
Tabula Rasa HealthCare Ticker
Tabula Rasa HealthCare FIGI
All fundamentals and in-depth analysis of Tabula Rasa HealthCare
Our stock analysis for Tabula Rasa HealthCare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tabula Rasa HealthCare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.